Lamotrigine in the treatment of pain syndromes and neuropathic pain

Bratislava Medical Journal

Volumn 109, Issue 9, 2008, Pages 421-424

  Titlic, Marina ^a   Jukic, I ^a   Tonkic, A ^a   Josipovic Jelic, Z ^b   Boschi, V ^a   Mihalj, M ^a   Punda, A ^a  

^a UNIVERSITY HOSPITAL SPLIT   (Croatia)

^b Policlinica Medikol   (Croatia)

Author keywords

Lamotrigine; Neuralgia; Pain

Indexed keywords

ANALGESIC AGENT; ANTICONVULSIVE AGENT; LAMOTRIGINE; TRIAZINE DERIVATIVE;

HUMAN; NEURALGIA; PAIN; REVIEW;

ANALGESICS; ANTICONVULSANTS; HUMANS; NEURALGIA; PAIN; TRIAZINES;

EID: 57049178966     PISSN: 00069248     EISSN: 13360345     Source Type: Journal    
DOI: None     Document Type: Review

References (46)

1. Cheung H, Kamp D, Harris E. An in vitro investigation of the action of lamotrigine on neural voltage-activated sodium channels. Epilepsy Res 1992; 13: 107-112.
2. Yuen WC, Peck AW. Lamotrigine pharmacokinetics: Oral and iv infusion in man. Epilepsy 1987; 28: 582-586.
3. Perruca E. The clinical pharmacology of the new antiepileptic drugs. Pharmacol Res 1993; 28: 89-106.
4. Vestergaard K, Andersen G, Gottrup H, Kristensen BT, Jensen TS. Lamotrigine for central posstroke pain: a randomized controlled trial. Neurology 2001; 56 (2): 184-190.
5. Frese A, Husstedt IW, Ringelstein EB, Evers S. Pharmacologic treatment of central post-stroke pain. Clin J Pain 2006; 22 (3): 252-260.
6. Finnerup NB, Gottrup H, Jensen TS. Anticonvulsants in central pain. Expert Opin Pharmacother 2002; 3 (10): 1411-1420.
7. Canavero S, Bonicalzi V. Drug therapy of trigeminal neuralgia. Expert Rev Neurother 2006; 6 (3): 429-440.
8. Zakrzewska JM, Chaudhry Z, Nurmikko TJ, Patton DW, Mullens EL. Lamotrigine (lamicatal) in refractory trigeminal neuralgia: results from a double-blind placebo controlled crossover trial. Pain 1997; 73 (2): 223-230.
9. Sindrup SH, Jensen TS. Pharmacotherapy of trigeminal neuralgia. Clin J Pain 2002; 18 (1): 22-27.
10. Jorns TP, Zakrzewska JM. Evidence-based approach to the medical management of trigeminal neuralgia. Br J Neurosurg 2007; 21 (3): 253-261.
11. Solaro C, Brichetto G, Battaglica MA, Messmer Uccelli M, Mancardi GL. Antiepileptic medications in multiple sclerosis: adverse effects in a three-year follow-up study. Neurol Sci 2005; 25 (6): 307-310.
12. Solaro C. Epidemiology and treatment of pain in multiple sclerosis subjects. Neurol Sci 2006; 27 Suppl 4: 291-293.
13. Rozen TD. Antiepileptic drugs in the management of cluster headache and trigeminal neuralgia. Headache 2001; 41 (Suppl 1): S25-32.
14. Piovesan EJ, Siow C, Kowacs PA, Werneck LC. Influence of lamotrigine over the SUNCT syndrome: one patients follow-up for twoyears. Arq Neuropsiquiatr 2003; 61 (3A): 691-694.
15. Alore PL, Jay WM, Macken MP. SUNCT syndrome: Short-lasting Unilateral Neuralgiform headache with Conjuctival injection and Tearing. Semin Ophthalmol 2006; 21 (1): 9-13.
16. Cohen AS, Matharu MS, Goadsby PJ. Trigeminal autonomic cephalalgias: current and future treatments. Headache 2007; 47 (6): 969-980.
17. Titlic M, Jukic I, Tonkic A, Grai P, Jukic J. Use of lamotrigine in glossopharyngeal neuralgia: a case report. Headache 2006; 46 (1): 167-169.
18. Guay DR. Adjunctive agents in the management of chronic pain. Pharmacotherapy 2001; 21 (9): 1070-1081.
19. Simpson DM, McArthur JC, Olney R, Clifford D, So Y, Ross D, Baird BJ, Barrett P, Hammer AE. Lamotrigine HIV Neuropathy Study Team. Neurology 2003; 60 (9): 1508-1514.
20. Eisenberg E, Alon N, Ishay A, Daoud D, Yarnitsky D. Lamotrigine in the treatment of painful diabetic neuropathy. Eur J Neurol 1998; 5 (2): 167-173.
21. McCleane G. 200 mg daily of lamotrigine has no analgetic effect in neuropathic pain: a randomised, double-blind, placebo controlled trial. Pain 1999; 83 (1): 105-107.
22. McCleane GJ. Lamotrigine in the management of neuropathic pain: a review of the literature. Clin J Pain 2000; 16 (4): 321-326.
23. Eisenberg E, Lurie Y, Braker C, Daoud D, Ishay A. Lamotrigine reduces painful diabetic neuropathy: a randomized, controlled study. Neurology 2001; 57 (3): 505-509.
24. Vu TN. Current pharmacologic approaches to treating neuropathic pain. Curr Pain Headache Rep 2004; 8 (1): 15-18.
25. Backonja MM, Serra J. Pharmacologic management part 1: better-studied neuropathic pain diseases. Pain Med 2004; 5 (Suppl 1): S28-47.
26. Singleton JR, Smith AG, Russell J, Feldman EL. Polyneuropathy with Impaired Glucose Tolarence: Implications for Diagnosis and Therapy. Curr Treat Options Neurol 2005; 7 (1): 33-42.
27. Vinik AI, Tuchman M, Safirstein B, Corder C, Kirby L, Wilks K, Quessy S, Blum D, Grainger J, White J, Silver M. Lamotrigine for treatment of pain associated with diabetic neuropathy: results of two randomized, double-blind, placebo-controlled studies. Pain 2007; 128 (1-2): 167-179.
28. Coderre TJ, Kumar N, Lefebvre CD, Yu JS. A comparison of the glutamate release inhibition and antiallodynic effects of gabapentin, lamotrigine, and riluzole in a model of neuropathic pain. J Neurochem 2007; 100 (5): 1289-1299.
29. Chong MS, Hester J. Diabetic painful neuropathy: current and future treatment options. Drugs 2007; 67 (4): 569-585.
30. Bisdorff AR. Tretment of migraine related vertigo with lamotrigine an observational study. Bull Soc Sci Med Frand Duche Luxemb 2004; 2: 103-108.
31. Sandner-Kiesling A, Rumpold Seitlinger G, Dorn C, Koch H, Schwarz G. Lamotrigine monotherapy for control of neuralgia after nerve section. Acta Anaesthesiol Scand 2002; 46 (10): 1261-1264.
32. Finnerup NB, Sindrup SH, Bach FW, Johannesen IL, Jensen TS. Lamotrigine in spinal cord injury pain: a randomized controlled trial. Pain 2002; 96 (3): 375-383.
33. Bonicalzi V, Canavero S, Cerutti F, Piazza M, Clemente M, Chió A. lamotrigine reduces total postoperative analgesic requirement: a randomized double-blind, placebo-controlled pilot study. Surgery 1997; 122 (3): 567-570.
34. Eisenberg E, Damunni G, Hoffer E, Baum Y, Krivoy N. lamotrigine for intractable sciatica: correlation between dose, plasma concentration and analgesia. Eur J Pain 2003; 7 (6): 485-491.
35. Landmark CJ. Targets for antiepileptic drugs in the synapse. Med sci Monit 2007; 13 (1): RA1-7.
36. Söderpalm B. Anticonvulsants: aspects of their mechanisms of action. Eur J Pain 2002; 6 (Suppl A): 3-9.
37. Jensen TS. Anticonvulsants in neuropathic pain: relationale and clinical evidence. Eur J Pain 2002; 6 (Suppl A): 61-68.
38. Backonja MM. Use of anticonvulsants for treatment of neuropathic pain. Neurology 2002; 58 (Suppl 2): S14-17.
39. Wiffen PJ, Rees J. Lamotrigine for acute and chronic pain. Cochrane Database Syst Rev 2007; (2): CD006044.
40. Delvaux V, Schoenen J. New generation anti-epileptics for facial pain and headache. Acta Neurol Belg 2001; 101 (1): 42-46.
41. Stepie A, Rzeski M. Trigemino-autonomic cephalalgias. Report of two cases. Neurol Neurochir Pol 2003; 37 (5): 1103-1111.
42. Gutierrez-Garcia JM. SUNCT syndrome responsive to lamotrigine. Headache 2002; 42 (8): 823-825.
43. Vu TN. Current pharmacologic approaches to treating neuropathic pain. Curr Pain Headache Rep 2004; 8 (1): 15-18.
44. Moulin DE, Clark AJ, Gilron I, Waew MA, Watson CP, Sessle BJ, Coderre T, Morley-Forster PK, Stinson J, Boulanger A, Peng P, Finley GA, Taenzer P, Squire P, Dion D, Cholkan A, Gilani A, Gordon A, Henry J, Jovey R, Lynch M, Mailis-Gagnon A, Panju A, Rollman GB, Velly A. Canadian Pain Society. Pharmacological management of chronic neuropathic pain - consensus statement and guidelines from the Canadian Pain Society. Pain Res Manag 2007; 12 (1): 13-21.
45. Eisenberg E, River Y, Shifrin A, Krivoy N. Antiepileptic drugs in the treatment of neuropathic pain. Drugs 2007; 67 (9): 1265-289.
46. Vinik A. Clinical review: Use of antiepileptic drugs in the treatment of chronic painful diabetic neuropathy. J Clin Endocrinol Metab 2005; 90 (8): 4936-4945.